Research published in Circulation: Cardiovascular Quality and Outcomes July 9 suggests the public health burden of pulseless in-hospital cardiac…

Biotronik on July 8 announced its BIOMONITOR III injectable cardiac monitor (ICM), a diagnostic tool designed to document suspected arrhythmias, has been cleared by the FDA.

The BIOMONITOR III device is 60% smaller…

Four universities were awarded research grants by the American Heart Association on June 24, each set to receive more than $3.7 million for a range of studies focused on arrhythmias and sudden cardiac arrest.

In a…

Researchers at the University of Washington are hoping to catch out-of-hospital cardiac arrests (OHCAs) early with an algorithm that, when integrated with smart speakers like the Google Home or Amazon Alexa, can monitor people for…

More than 14 million European adults aged 65 and up will have developed atrial fibrillation by 2060, according to a paper published June 6 in…

Biotronik is targeting a minimum of 40% female enrollment for its newest project, a large-scale prospective study of sex differences in patients with non-ischemic cardiomyopathy (NICM) and an implanted cardiovascular device.

Heart patients prone to emotionally triggered atrial fibrillation are less likely to experience an arrhythmia if they’re taking beta-blockers, according to a June 3 study published in…

Former heart patient Donald Scott gifted Loyola Medicine $1.5 million last week as a thank-you for the care he received there when he suffered an arrhythmia, Loyola announced May 31.

According to the university’s…

The so-called “weekend effect”—that idea that patients admitted to the hospital on Saturdays, Sundays and holidays face greater odds of readmission down the line—doesn’t apply to victims of cardiac arrest, according to data presented at…

Consuming 32 ounces or more of an energy drink within an hour could raise blood pressure and trigger life-threatening arrhythmias, according to research published ahead of print in the…

People living in the Canadian province of Manitoba are facing up to 70-week waits for elective echocardiograms, CBC reported May 28—dozens of weeks longer than those living in neighboring Saskatchewan and Ontario provinces.

Women are less likely to be resuscitated by bystanders than men in cases of out-of-hospital cardiac arrest (OHCA), and when resuscitation is attempted they see lower survival rates, according to research published in the…

An absorbable, antibiotic-eluting mesh envelope significantly reduced the incidence of major cardiac implantable electronic device (CIED) infections in a recent study of nearly 7,000 patients, researchers reported in the…

A six-week online training course centered around living with an implantable cardioverter-defibrillator (ICD) helped alleviate anxiety in heart failure patients who were apprehensive about their devices.

Study head…

Researchers at Florida Atlantic University’s College of Engineering and Computer Science have developed an algorithm that can identify precise internal targets for ablation in atrial fibrillation patients—the first, they say, that can…

A high intake of grapefruit juice—and other dietary flavonoids found in fruits, vegetables, tea and wine—could correspond to QT interval prolongation in healthy individuals and those with heart disease, leaving them vulnerable to…

A trio of studies presented at the Heart Rhythm Society’s 40th annual scientific sessions earlier this month highlight significant disparities in patient access to implantable cardiac devices—particularly in women and black patients.…

The FDA is updating azithromycin drug labels to reflect evidence that the medication can contribute to a rare heart rhythm abnormality known as torsades de pointes.

The safety of azithromycin, an antibacterial drug…

The Heart Rhythm Society issued a first-ever…

South Korean researchers are working on packing the ability to monitor heart health and detect signs of atrial fibrillation into what might be the smallest cardiology wearable to date: a “smart ring.”

The proposed…

BioCardia’s AVANCE steerable introducer family has received FDA 510(k) clearance, the company announced May 8.

The AVANCE family, according to a…